CN105582883A - Activated diatomaceous earth and application of diatomaceous earth in production of blood products - Google Patents

Activated diatomaceous earth and application of diatomaceous earth in production of blood products Download PDF

Info

Publication number
CN105582883A
CN105582883A CN201510985707.7A CN201510985707A CN105582883A CN 105582883 A CN105582883 A CN 105582883A CN 201510985707 A CN201510985707 A CN 201510985707A CN 105582883 A CN105582883 A CN 105582883A
Authority
CN
China
Prior art keywords
diatomite
diatomaceous earth
filter
washing
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510985707.7A
Other languages
Chinese (zh)
Other versions
CN105582883B (en
Inventor
石清东
莫丽影
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Haomei Cell Gene Biotechnology Co ltd
Original Assignee
BEIHAI KAIYUAN BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIHAI KAIYUAN BIOLOGICAL TECHNOLOGY Co Ltd filed Critical BEIHAI KAIYUAN BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201510985707.7A priority Critical patent/CN105582883B/en
Publication of CN105582883A publication Critical patent/CN105582883A/en
Application granted granted Critical
Publication of CN105582883B publication Critical patent/CN105582883B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/14Diatomaceous earth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses activated diatomaceous earth and an application of diatomaceous earth in production of blood products. In production of the blood products, the diatomaceous earth is required to be used in a common low-temperature ethanol filter press separation method and acts as a filter aid for solid-liquid separation or an adsorbent, but the diatomaceous earth can produce dust in the use process and blocks an air conditioning unit and a room air filter; secondly, the diatomaceous earth easily enters a filter press plate to block filter holes, thereby causing high filter pressure and prolonging of filter time; thirdly, although the diatomaceous earth is treated before the diatomaceous earth leaves the factory, metal ions in the diatomaceous earth affect the ion strength of a product solution, and abnormal yield and stability of different batches are caused. The activated diatomaceous earth is obtained through steps as follows: dry roasting, acid pickling, water washing and ethanol washing and is applied to production of the blood products. The metal ions or oxides are removed, the diatomaceous earth is filtered by a 600-mesh stainless steel filter net, fine particles gradually pass through the filter net during washing in each step, and the purpose of separation of the fine particles from the diatomaceous earth is achieved.

Description

A kind of activate diatomite and blood product produce in application
Technical field
What the present invention relates to is a kind of activation diatomite, also relates to the application of described activation diatomite in blood product is produced, and belongs to field of biological pharmacy.
Background technology
Diatomite mainly by ancient times silicon fall and the siliceous remains of other microorganisms form, its 80%~90%, even more than 90% chemical composition is SiO2, also have a small amount of Al2O3、Fe2O3, CaO, MgO etc. Diatomite stable performance, have acidproof, pore volume is large, aperture is large, specific area is large, adsorptivity is strong, can adsorb the liquid of 1.5~4 times of sole masses, the wet goods character of 11~15 times of sole masses of absorption. Be widely applied as filter aid, adsorbent, filler, catalyst carrier, abrasive material reinforcing agent and animal feed replenishers etc. in many industries such as environment, chemical industry, oil, building materials, medicine manufactures.
In the production technology of blood product, at present the most frequently used is exactly cold ethanol press filtration partition method, the diatomite all can additional proportion in each step separation process not waiting, and its effect has two kinds: a kind of is the filter aid of Separation of Solid and Liquid, and the 2nd, as adsorbent. But in use usually there is following several problem: first, diatomite is added in goods with dry powder form conventionally, how slow the speed no matter adding have, how attention control, but because diatomite density is little, in the process adding, all can produce airborne dust, stop up in the course of time air-conditioning unit and space air filter. Secondly, filter press plate is a kind of principle of in-depth filtration, diatomite particle heterogeneity, and first tiny particle easily enters in filter press plate, stops up filter opening, causes in filter process pressure large, and filtration time extends and increases pollution risk impact and produce. The 3rd, although before diatomite dispatches from the factory, to do some and processed, the existence of metal ion (such as some metal ions or its oxide), more or less affects goods solution ion strength, and between causing batch, yield, stability is abnormal.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of activate diatomite and the application in blood product is produced, and solves diatomite as the generation airborne dust occurring in filter aid use procedure, stops up filter press plate filter opening, the problem that contains impurity metal ion.
For the problems referred to above, adopt following technique measures, a kind of activation diatomite, is activated by following method:
1. dry roasting: weigh pending diatomaceous weight, be placed in stainless steel cask and put into 180 DEG C of hot air drying ovens, heating 120min, leaves standstill and naturally cool to room temperature;
2. pickling: the diatomite after dry baking is placed in to the pyrogen-free diatomite container handling of pretreatment, add the water for injection of 2 times of diatomite weight, adding glacial acetic acid to make ultimate density is 0.20 ~ 0.30mol/L, agitator treating 1 hour, discharge washing raffinate, repeat said process 1-2 time;
3. washing: in diatomite container handling, add the water for injection of 2 times of diatomite weight, slowly agitator treating 30min, discharges washing raffinate after washing, repeat said process 1-2 time, is 5-7 until washing raffinate is measured pH value;
4. alcohol wash: according to the ethanolic solution of the concentration of alcohol preparation same concentrations of cold ethanol method separating blood product producing process separating step, in diatomite container handling, add the ethanolic solution of the described concentration weighing with diatomite etc., stir after 10~20 minutes, discharge cleaning solution, so operation repeats once, obtains activation diatomite.
Adopt the present invention of said method activation, the advantage of its activation method is the washing through several steps, remove corresponding metal ion or oxide, reduced the impact of cold ethanol intermediate ion intensity on separating effect, product quality and yield are further ensured. And through the filtration of 600 order stainless steel filtering nets, little fine grained, in the washing of each step, sees through filter screen gradually, reach the object that separates diatomite fine particle. And in whole process, mixing speed is unhappy, can not bring injury to diatomite. Main diatomite adds in hygrometric state mode, avoids the obstruction of airborne dust to cleaning shop air filtering system.
In actual application by adding after the present invention, no matter also can be reflected qualitatively from filter pressure, yield and final products. The present invention's filtering velocity in press filtration is fast, has greatly shortened filtration time, and the pollution because of artificial participation that filtration difficulty brings is reduced to minimum. Simultaneously in diatomite, contained metal ion or oxide be after treatment, its content is little, the impact that cold ethanol method in blood product is separated to each component reduces greatly, differences between batches reduce, product quality is further ensured, effective low obstruction that reduces air conditioner filter, product stability, yield also improve greatly.
Brief description of the drawings
Fig. 1 is the structural representation of diatomite container handling.
Detailed description of the invention
Embodiment 1
Diatomaceous activation
1. dry roasting: weigh pending diatomite 50kg and be placed in stainless steel cask, put into when hot air drying oven temperature reaches 180 DEG C and start timing, heating 120min, powered-down, leaves standstill that nature is cooling treats that temperature is reduced to room temperature;
2. pickling: rinse the diatomite processor of precoating alkali with water for injection, pour cooled diatomite into after qualified to pyrogen testing, add water for injection 100Kg, adding glacial acetic acid 1500ml under slowly stirring, agitator treating 1h, discharges washing raffinate; So repeat once;
3. washing: in diatomite container handling, add 100Kg water for injection, stirring at low speed washing 30min, discharges washing raffinate after washing; So repeating 1-2 time, is 5-7 until washing raffinate is measured pH value;
4. alcohol wash: according to the ethanolic solution of the concentration of alcohol preparation same concentrations of cold ethanol method separating blood product producing process separating step, in diatomite container handling, add 50 kilograms of the ethanolic solutions of same concentrations, stir after 10~20 minutes, discharge cleaning solution, so operation repeats once, obtains activation diatomite; The concentration of alcohol of described cold ethanol method separating blood product producing process separating step refers in existing cold ethanol method technique, as component I in human serum albumin separates corresponding concentration of alcohol 8%-10%(V/V), when component I I+III separates, corresponding concentration of alcohol is 20%-25%(V/V), it is 40%-42%(V/V that component I V, component V separate corresponding concentration of alcohol), human immunoglobulin(HIg) based article component III separates corresponding concentration of alcohol 14-17%, and component I I separates corresponding concentration of alcohol 23-27%(v/v).
Described diatomite container handling as shown in Figure 1, comprises container body 4, is provided with motor 1 at container body 4 tops, and motor 1 drives paddle 3 to rotate, and is provided with 600 order stainless steel filtering nets 2 in the bottom of container body 4. When use, diatomite and cleaning solution wash in diatomite container handling, and motor 1 drives paddle 3 rotations that diatomite is fully washed, and 600 order stainless steel screen packs 2 of container bottom can separate small particles.
Application Example 2
The present invention applies in quiet note human immunoglobulin(HIg)
Step 1F I supernatant is made
Blood plasma temperature after merging is controlled to 0 DEG C, regulating protein concentration with 0 DEG C of physiological saline is 5.1%, with pH4.0HAc-NaAc buffer solution adjusting pH to 7.10 ± 0.05, adding-15 DEG C of following ethanol to make ethanol ultimate density is 8% (v/v), limit adds the cooling of ethanol limit, final temperature is controlled at-2.5 DEG C, stirring reaction 1 hour. To the diatomite 4 ~ 8Kg (alcohol wash step concentration of alcohol is 8% (v/v)) that adds activation in every kilolitre solution, stir press filtration after 40 minutes and separate, isolate F I precipitation, collect F I supernatant.
The separation of step 2F II+III precipitation
Metering F I supernatant volume, with pH4.0HAc-NaAc buffer solution adjusting F I supernatant pH value to 6.95 ± 0.15, adding-15 DEG C of following ethanol to make ethanol ultimate density is 20% (v/v), limit adds the cooling of ethanol limit, solution final temperature-5.0 DEG C, stirring reaction 2 hours, to the diatomite 4 ~ 8Kg (alcohol wash step concentration of alcohol is 20% (v/v)) that adds activation in every kilolitre solution, stirring press filtration after 40 minutes separates, filtrate is F II+III supernatant, make and separate for F IV-1, collect F II+III precipitation.
The making of step 3F III supernatant
F II+III precipitation is dissolved with the sodium dihydrogen phosphate of 2~8 DEG C of 0.01M of 6 ~ 7 times of weight, adjust pH to 5.00 ~ 5.10 with 2mol/LHAc, temperature is controlled to-1.0 ~-3.0 DEG C, adding-15 DEG C of following ethanol to make ethanol ultimate density is 17% (v/v), stir after 3 ~ 4 hours, to the diatomite 4 ~ 8Kg (alcohol wash step concentration of alcohol is 17% (v/v)) that adds activation in every kilolitre solution, stirring reaction is press filtration separation after 1 hour, collecting filtrate is F III supernatant, and precipitation is abandoned.
The separation of step 4F II precipitation
Metering F III supernatant volume, adds sodium chloride by 5g/L. With 1mol/LNaOH solution adjusting F III supernatant pH value to 6.9 ~ 7.1, adding-15 DEG C of following ethanol to make ethanol ultimate density is 25% (v/v), limit adds the cooling of ethanol limit, solution is finally controlled at-5.5 DEG C ~--6.0 DEG C., stirring reaction 2 hours, leave standstill after 2 hours, to the diatomite 4 ~ 8Kg (alcohol wash step concentration of alcohol is 25% (v/v)) that adds activation in every kilolitre solution, stirring reaction is press filtration separation after 1 hour, is precipitated as F II precipitation, and supernatant is abandoned.
Dissolving and the ultrafiltration dialysis of step 5F II precipitation
By 4 ~ 5 times of F II precipitation weight, 2 ~ 8 DEG C of waters for injection dissolve F II precipitation, and 2mol/L glacial acetic acid regulates PH to 3.8 ~ 4.4, dissolves after 4 hours and leaves standstill and filter, and filtrate is F II solution. By F II solution through ultrafiltration concentration to protein concentration 4.0~8.0%, with the continuous equal-volumes dialysis of 6 times of 2 ~ 8 DEG C of waters for injection, and be concentrated into protein concentration 6.0~8.0%, stop concentrating. Protein concentration is controlled to 5.0%~6.0% with water for injection, adjusts pH to 4.70~5.30 with 2mol/LHAc, adding sorbitol concentration is 28.0%~35.0%.
Step 6 pasteurization
The solution preparing is put in pasteurization tank, at the temperature of 59.5 ~ 60.5 DEG C, heated and within 10 hours, carry out pasteurization.
Step 7 purification refine
Pasteurization is complete, carry out ultrafiltration dialysis for the second time, after removing sorbierite, protein concentration is controlled between 1.4~2.5%, control temperature-4.0~-5.0 DEG C of solution, adding-15 DEG C of following ethanol to make ethanol ultimate density is 17% (v/v), with 2mol/LHAc or 1mol/LNaOH rectification goods pH to 5.15~5.30. After making, stir half an hour add above diatomite (alcohol wash step ethanol content is 17%) (4Kg diatomite/1000L goods) stir again 1 hour leave standstill 4~8 hours, press filtration separate. Collect filtrate, precipitation is abandoned.
Step 8 ultrafiltration for the third time and semi-finished product preparation
Filtrate is carried out to ultrafiltration for the third time, remove ethanol, salt, and be concentrated into protein concentration 4.0~8.0%. With 0.5mol/LHCl tune pH to 3.80~4.40, interpolation maltose is to maltose content at 90~110g/L, and dilute solution is to protein content > 5.0%. Again through incubated at low pH, degerming packing, censorship, lamp inspection, packaging, warehouse-in.
Table 1: effect contrast in quiet note human immunoglobulin(HIg)
Application Example 3
The application of the present invention in human serum albumin
The making of step 1F IV-1 supernatant
With step 2 gained F II+III supernatant pH5.25 in pH4.0HAc-NaAc buffer solution adjusting embodiment 2, control solution temperature-5.0 DEG C, drip ethanol to concentration 40% (v/v), to the diatomite 4~6kg (alcoholysis step concentration of alcohol is 40% (v/v)) that adds activation in every kilolitre solution, stirring reaction 40 minutes, press filtration, filtrate is F IV-1 supernatant.
The making of step 2F IV-4 supernatant
Metering F IV-1 supernatant volume, with 1mol/L sodium bicarbonate solution adjusting supernatant PH to 5.9 ± 0.05, F IV-1, temperature is-5.0 ± 0.05 DEG C, adding-15 DEG C of following ethanol to make ethanol ultimate density is 40% (v/v),, to the diatomite 5~7kg (alcohol wash step concentration of alcohol is 40% (v/v)) that adds activation in every kilolitre solution, stirring reaction 2 hours, press filtration, filtrate is F IV-4 supernatants.
Step 3F V precipitate and separate
Metering F IV-4 supernatant volume, with 2mol/LHAc-40% ethanolic solution adjusting supernatant pH to 4.8 ± 0.05, F IV-4, temperature is-7.5 ± 0.05 DEG C, drip ethanol to concentration 40% (v/v), to the diatomite 3~6kg (alcohol wash step concentration of alcohol is 40% (v/v)) that adds activation in every kilolitre solution, stirring reaction 1 hour, press filtration, is precipitated as F V precipitation.
Step 4F V deposition and purification
8% ethanolic solution (0 DEG C~5 DEG C) stirring and dissolving of 5 times of volumes for F V precipitation, cooling while stirring, until precipitation is dissolved completely. With pH4.0HAc-NaAc buffer solution tune pH to 4.55 ± 0.05. Continue to stir more than 1 hour, the control of goods final temperature is-2.5 DEG C ± 0.5 DEG C, leaves standstill more than 2 hours press filtration and separates.
Get filtrate and carry out ultrafiltration, be concentrated into protein concentration 10%~15%, first use 5 times of isopyknic 0.9% normal saline dialysis, then dialyse with 3 times of isopyknic waters for injection, after dialysis finishes, gained is albumin stoste. Regulate pH value to should be 6.60~7.20, the dosage of Sodium Caprylate is pressed 0.160mmol/g protein, with water for injection, goods being diluted to protein content is 195~205g/L, bath temperature is controlled at 60.0 DEG C, after constant temperature 10 hours, be down to room temperature, aseptic filtration, censorship, lamp inspection and visible foreign matters inspection, the qualified rear packaging of lamp inspection, warehouse-in.
Table 2: effect contrast in human serum albumin

Claims (2)

1. an activation diatomite, is characterized in that described activation diatomite is activated by following method:
(1) dry roasting: weigh pending diatomaceous weight, be placed in stainless steel cask and put into 180 DEG C of hot air drying ovens, heating 120min, leaves standstill and naturally cool to room temperature;
(2) pickling: the diatomite after dry baking is placed in to the pyrogen-free diatomite container handling of pretreatment, add the water for injection of 2 times of diatomite weight, adding glacial acetic acid to make ultimate density is 0.20 ~ 0.30mol/L, agitator treating 1 hour, discharge washing raffinate, repeat said process 1-2 time;
(3) washing: in diatomite container handling, add the water for injection of 2 times of diatomite weight, slowly agitator treating 30min, discharges washing raffinate after washing, repeat said process 1-2 time, is 5-7 until washing raffinate is measured pH value;
(4) alcohol wash: the concentration of alcohol of the separating step according to diatomite in quiet note human immunoglobulin(HIg) and human serum albumin application, the ethanolic solution of preparation same concentrations, in diatomite container handling, adds the ethanolic solution of the described concentration weighing with diatomite etc.,
After agitator treating 10-20min, discharge ethanolic solution, so repeat said process 2 times, obtain activation diatomite.
2. activate diatomite application as filter aid in blood product is produced.
CN201510985707.7A 2015-12-25 2015-12-25 A kind of activated diatomaceous earth and the application in blood product production Active CN105582883B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510985707.7A CN105582883B (en) 2015-12-25 2015-12-25 A kind of activated diatomaceous earth and the application in blood product production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510985707.7A CN105582883B (en) 2015-12-25 2015-12-25 A kind of activated diatomaceous earth and the application in blood product production

Publications (2)

Publication Number Publication Date
CN105582883A true CN105582883A (en) 2016-05-18
CN105582883B CN105582883B (en) 2017-12-15

Family

ID=55923004

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510985707.7A Active CN105582883B (en) 2015-12-25 2015-12-25 A kind of activated diatomaceous earth and the application in blood product production

Country Status (1)

Country Link
CN (1) CN105582883B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107090026A (en) * 2017-03-27 2017-08-25 武汉中原瑞德生物制品有限责任公司 Utilize the method and system of diatomite separated plasma albumen from blood product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044233A (en) * 1988-09-30 1990-08-01 广西化工研究所 The method for preparing filter aid with diatomite
US20040097710A1 (en) * 2002-11-19 2004-05-20 Kalevi Visuri Method for the crystallization of human serum albumin
CN103087184A (en) * 2013-01-14 2013-05-08 山西康宝生物制品股份有限公司 Method for controlling prekallikrein activator in human serum albumin product
CN103143318A (en) * 2012-12-06 2013-06-12 中国科学院合肥物质科学研究院 Preparation method for siliceous earth/FeOOH composite materials in micro-nano structure

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044233A (en) * 1988-09-30 1990-08-01 广西化工研究所 The method for preparing filter aid with diatomite
US20040097710A1 (en) * 2002-11-19 2004-05-20 Kalevi Visuri Method for the crystallization of human serum albumin
CN103143318A (en) * 2012-12-06 2013-06-12 中国科学院合肥物质科学研究院 Preparation method for siliceous earth/FeOOH composite materials in micro-nano structure
CN103087184A (en) * 2013-01-14 2013-05-08 山西康宝生物制品股份有限公司 Method for controlling prekallikrein activator in human serum albumin product

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107090026A (en) * 2017-03-27 2017-08-25 武汉中原瑞德生物制品有限责任公司 Utilize the method and system of diatomite separated plasma albumen from blood product

Also Published As

Publication number Publication date
CN105582883B (en) 2017-12-15

Similar Documents

Publication Publication Date Title
JP6676073B2 (en) Continuous elution of products from chromatography columns
CN103333240B (en) Method for reclaiming human albumin from component IV precipitate
CN101972479B (en) Preparation process of intravenous injection human immunoglobulin
CN104672328B (en) A kind of production method of Human Antithrombin Ⅲ
CN103554253B (en) A kind of preparation method of quiet note human normal immunoglobulin
CN101974070B (en) Preparation process of human prothrombin compound
CN105601736B (en) A kind of anti respiratory syncytial virus human immunoglobulin(HIg) and preparation method thereof
CN101619308A (en) Preparation method for extracting lysozyme from egg white
CN104328101A (en) Preparation method of thrombin
CN104402993A (en) Method for preparing human immunoglobulin for intravenous injection
CN106676089B (en) Method for preparing human prothrombin complex from blood plasma
CN104450639B (en) A kind of method using ultrafiltration auxiliary aqueous two phase extraction technique extraction lactoperoxidase
CN104558156A (en) Method for extracting human serum albumin from plasma and increasing yield
CN105582883A (en) Activated diatomaceous earth and application of diatomaceous earth in production of blood products
CN114181300A (en) Preparation method of high-purity monoclonal antibody
CN104311628B (en) A kind of protein solution bacterial endotoxin minimizing technology
CN106455621B (en) Egg white treatment
CN101439047B (en) Technological process for improving stable FVII yield of human prothrombin complexes
CN106188189B (en) A kind of nucleosides acid mother liquor desalination and concentration method
CN108084258A (en) A kind of efficiently convenient removing endotoxic method of albumin solution
CN207328066U (en) Air conditioning for automobiles removes musty air cleaning unit
CN107090026B (en) Method and system for separating plasma protein from blood product using diatomite
CN104193822B (en) Process for preparing rabies human immune globulin
RU2488634C1 (en) Method to produce dna from salmon roe
CN102268418A (en) Method for purifying lysozyme from milk

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220905

Address after: Room 103-159, building 18, courtyard 1, gaolizhang Road, Haidian District, Beijing 100095

Patentee after: BEIJING HAOMEI CELL GENE BIOTECHNOLOGY Co.,Ltd.

Address before: 804, No. 126, Beihai Avenue, Haicheng District, Beihai City, Guangxi Zhuang Autonomous Region, 536000

Patentee before: BEIHAI KAIYUAN BIOLOGICAL TECHNOLOGY Co.,Ltd.